Product Overview
Our DynaGraft® II grafts combine demineralized bone matrix with a bioresorbable, reverse phase medium carrier. The graft is provided in a syringe or vial and requires no preoperative preparation.
Key Features:
• Superior Handling - The unique, poloxamer, reverse phase medium carrier, which becomes more viscous at body temperature, provides exceptional handling and containment characteristics. The graft is moldable, packable, mixable with other grafting materials and irrigation resistant.
• Verified Osteoinductive Potential - Every lot of DBM is tested in a validated, in vitro assay to verify osteoinductive potential.
• Expert Processing - Cortical bone obtained from AATB-accredited tissue banks is processed into DBM in our state-of-the-art facility. The demineralization process is tightly controlled to consistently produce demineralized bone.
• Electron Beam Sterilization - The processing of DBM and ABM is completed under aseptic conditions in our state-of-the-art facility. As the last step in manufacturing, the graft is sterilized via electron beam irradiation.
Indications:
DynaGraft II is indicated for orthopedic applications as filler for gaps or voids that are not intrinsic to the stability of the bony structure. DynaGraft II is indicated to be packed gently into bony gaps in the skeletal system as a bone graft extender (extremities, spine, pelvis) and as bony void filler of the extremities and pelvis. These defects may be surgically created or from the result of traumatic injury to the bone. (https://www.seaspine.com)
